Seeking Alpha

Late Monday, the FDA approved the use of Merck's (MRK) Sylatron drug to treat skin cancer in...

Late Monday, the FDA approved the use of Merck's (MRK) Sylatron drug to treat skin cancer in patients with node-positive melanoma following the removal of the affected part. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs